Related Experiment Video
Updated: Sep 8, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Clinical Outcomes in Patients With Quadricuspid vs Bicuspid Aortic Valve
Jingnan Zhang1,2, Fang Fang3, Zhiyuan Xia3
1Division of Cardiology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Quadricuspid aortic valve (QAV) and bicuspid aortic valve (BAV) both require interventions. QAV increases heart failure hospitalization risk, while BAV is linked to infective endocarditis and aortic surgery, though survival is similar for both conditions.
Area of Science:
- Cardiovascular Medicine
- Congenital Heart Disease
- Valvular Heart Disease
Background:
- Congenital aortic valve disease is common, with bicuspid aortic valve (BAV) being the most frequent type.
- Quadricuspid aortic valve (QAV) is a rare congenital anomaly, and its clinical outcomes compared to BAV are not well-established.
- Understanding the distinct clinical trajectories of QAV and BAV is crucial for patient management and risk stratification.
Purpose of the Study:
- To compare the clinical outcomes between patients diagnosed with quadricuspid aortic valve (QAV) and bicuspid aortic valve (BAV).
- To investigate differences in the rates of aortic valve intervention, aortic surgery, aortic dissection, infective endocarditis, heart failure hospitalization, and all-cause mortality between QAV and BAV cohorts.
- To assess the long-term survival relative to the general population for individuals with QAV versus BAV.
Main Methods:
- A retrospective cohort study was conducted using echocardiographic data from January 1, 2011, to December 31, 2023, at two tertiary hospitals in China.
- Patients diagnosed with QAV or BAV were identified, with QAV patients propensity score matched 1:5 to BAV patients based on age and sex.
- Outcomes including aortic valve intervention, aortic surgery, aortic dissection, infective endocarditis (IE), heart failure hospitalization (HFH), and all-cause death were analyzed using cumulative incidence functions and multivariable adjustments.
Main Results:
- The study included 139 QAV patients and 695 BAV patients, followed for a median of 4.8 years.
- Both QAV and BAV cohorts showed similar rates of aortic valve intervention (77.4% vs 75.7%).
- QAV patients had a lower incidence of aortic surgery (5.1% vs 33.8%) and IE (0% vs 9.6%) but a higher risk of HFH (adjusted hazard ratio [AHR], 2.52) compared to BAV patients. Cardiomyopathy was an independent predictor of HFH in QAV patients (AHR, 4.27).
- Aortic dissection was rare in both groups. The 5-year relative survival rates were comparable to the general population for both QAV (102.9%) and BAV (102.4%).
Conclusions:
- Both QAV and BAV are associated with a high need for aortic valve intervention.
- QAV is linked to an increased risk of heart failure hospitalization, whereas BAV is associated with higher rates of infective endocarditis and aortic surgery.
- Despite significant morbidity, long-term survival for patients with QAV or BAV is similar to that of the general population.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management

